Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1493
https://www.valueinhealthjournal.com/article/S1098-3015(17)31827-2/fulltext
Title :
Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31827-2&doi=10.1016/j.jval.2017.08.1493
First page :
A646
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1343